CDH1 and breast cancer: Besides it was reported that miR-373 can enhance the levels of the mesenchymal markers, including β-catenin, N-cadherin and vimentin, and decrease the level of the epithelial markers, E-cadherin and claudin, contributing to BC enhanced cells invasiveness and metastasis development [40].